85 related articles for article (PubMed ID: 16331247)
1. Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients.
Tanaka Y; Kanai F; Tada M; Asaoka Y; Guleng B; Jazag A; Ohta M; Ikenoue T; Tateishi K; Obi S; Kawabe T; Yokosuka O; Omata M
Oncogene; 2006 May; 25(20):2950-2. PubMed ID: 16331247
[TBL] [Abstract][Full Text] [Related]
2. Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population.
Kostakis GC; Papadogeorgakis N; Koumaki V; Kamakari S; Koumaki D; Alexandridis C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):e53-8. PubMed ID: 20416519
[TBL] [Abstract][Full Text] [Related]
3. Rare PIK3CA hotspot mutations in carcinomas of the biliary tract.
Riener MO; Bawohl M; Clavien PA; Jochum W
Genes Chromosomes Cancer; 2008 May; 47(5):363-7. PubMed ID: 18181165
[TBL] [Abstract][Full Text] [Related]
4. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678
[TBL] [Abstract][Full Text] [Related]
5. Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.
Barbareschi M; Buttitta F; Felicioni L; Cotrupi S; Barassi F; Del Grammastro M; Ferro A; Dalla Palma P; Galligioni E; Marchetti A
Clin Cancer Res; 2007 Oct; 13(20):6064-9. PubMed ID: 17947469
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA gene mutations in pediatric and adult glioblastoma multiforme.
Gallia GL; Rand V; Siu IM; Eberhart CG; James CD; Marie SK; Oba-Shinjo SM; Carlotti CG; Caballero OL; Simpson AJ; Brock MV; Massion PP; Carson BS; Riggins GJ
Mol Cancer Res; 2006 Oct; 4(10):709-14. PubMed ID: 17050665
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
[TBL] [Abstract][Full Text] [Related]
9. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA mutations in breast cancer are associated with poor outcome.
Li SY; Rong M; Grieu F; Iacopetta B
Breast Cancer Res Treat; 2006 Mar; 96(1):91-5. PubMed ID: 16317585
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients.
Lai YL; Mau BL; Cheng WH; Chen HM; Chiu HH; Tzen CY
Ann Surg Oncol; 2008 Apr; 15(4):1064-9. PubMed ID: 18183466
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics of PIK3CA and HBx mutations in Korean patients with hepatocellular carcinomas.
Kim DC; Chung WJ; Lee JH; Jang BK; Hwang JS; Kang KJ; Kwon SY
APMIS; 2014 Oct; 122(10):1001-6. PubMed ID: 24673525
[TBL] [Abstract][Full Text] [Related]
13. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations.
Hafner C; Landthaler M; Vogt T
Exp Dermatol; 2010 Aug; 19(8):e222-7. PubMed ID: 20557351
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women.
Maruyama N; Miyoshi Y; Taguchi T; Tamaki Y; Monden M; Noguchi S
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):408-14. PubMed ID: 17202311
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma.
Buttitta F; Felicioni L; Barassi F; Martella C; Paolizzi D; Fresu G; Salvatore S; Cuccurullo F; Mezzetti A; Campani D; Marchetti A
J Pathol; 2006 Feb; 208(3):350-5. PubMed ID: 16353168
[TBL] [Abstract][Full Text] [Related]
16. PIK3CA cancer mutations display gender and tissue specificity patterns.
Benvenuti S; Frattini M; Arena S; Zanon C; Cappelletti V; Coradini D; Daidone MG; Pilotti S; Pierotti MA; Bardelli A
Hum Mutat; 2008 Feb; 29(2):284-8. PubMed ID: 18022911
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma.
Nomoto S; Yamashita K; Koshikawa K; Nakao A; Sidransky D
Clin Cancer Res; 2002 Feb; 8(2):481-7. PubMed ID: 11839667
[TBL] [Abstract][Full Text] [Related]
18. PIK3CA mutation and amplification in human lung cancer.
Okudela K; Suzuki M; Kageyama S; Bunai T; Nagura K; Igarashi H; Takamochi K; Suzuki K; Yamada T; Niwa H; Ohashi R; Ogawa H; Mori H; Kitamura H; Kaneko T; Tsuneyoshi T; Sugimura H
Pathol Int; 2007 Oct; 57(10):664-71. PubMed ID: 17803655
[TBL] [Abstract][Full Text] [Related]
19. PIK3CA amplification is predictive of poor prognosis in Tunisian patients with nasopharyngeal carcinoma.
Fendri A; Khabir A; Mnejja W; Sellami-Boudawara T; Daoud J; Frikha M; Ghorbel A; Gargouri A; Mokdad-Gargouri R
Cancer Sci; 2009 Nov; 100(11):2034-9. PubMed ID: 19735264
[TBL] [Abstract][Full Text] [Related]
20. PIK3CA gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by PIK3CA pseudogene sequences.
Miyake T; Yoshino K; Enomoto T; Takata T; Ugaki H; Kim A; Fujiwara K; Miyatake T; Fujita M; Kimura T
Cancer Lett; 2008 Mar; 261(1):120-6. PubMed ID: 18180098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
